Hormone replacement therapy and risk of non-fatal stroke

Lancet

Volumn 350, Issue 9087, 1997, Pages 1277-1283

  Pedersen, Anette Tønnes ^a   Lidegaard, Øjvind ^b   Kreiner, Svend ^a   Ottesen, Bent ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CONTROLLED STUDY; DENMARK; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK; STROKE; SUBARACHNOID HEMORRHAGE; TRANSIENT ISCHEMIC ATTACK;

EID: 0013520974     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)06005-4     Document Type: Article

References (33)

1. Lindestrøm E, Boysen G, Nyboe J, Appleyard M. Stroke incidence in Copenhagen, 1976-1988. Stroke 1992; 23: 28-32.
2. Falkeborn M, Persson I, Terént A, Bergström R, Lithell H, Naessén T. Long-term trends in incidence of and mortality from acute myocardial infarction and stroke in women: analyses of total first events and of deaths in the Uppsala Health Care Region, Sweden. Epidemiology 1996; 7: 67-74.
3. Zhang XH, Sasaki S, Kesteloot H. Changes in the sex ratio of stroke mortality in the period of 1955 through 1990. Stroke 1995; 26: 1774-80.
4. Grodstein F, Stampfer MJ. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis 1995; 38: 199-210.
5. Pfeffer RI. Estrogen use, hypertension and stroke in postmenopausal women. J Chron Dis 1978; 31: 389-98.
6. Petitti DB, Wingerd J, Pellegrin F, Ramcharan S. Risk of vascular disease in women: smoking, oral contraceptives, noncontraceptive estrogens and other factors. JAMA 1979; 242: 1150-54.
7. Hammond CB, Jelovsek FR, Lee KL, Creasman WT, Parker RT. Effects of long-term estrogen replacement therapy: metabolic effects. Am J Obstet Gynecol 1979; 133: 525-36.
8. Rosenberg SH, Fausone V, Clark R. The role of estrogens as a risk factor for stroke in postmenopausal women. West J Med 1980; 133: 292-96.
9. Wilson PWF, Garrison RJ, Castelli WP. Postmenopausal estrogen use, cigarette smoking and cardiovascular morbidity in women over 50: the Framingham study. N Engl J Med 1958; 313: 1038-43.
10. Busch TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987; 75: 1102-09.
11. Boysen G, Nyboe J, Appleyard M, et al. Stroke incidence and risk factors for stroke in Copenhagen, Denmark. Stroke 1988; 19: 1345-53.
12. Paganini-Hill A, Ross RK, Henderson BE. Postmenopausal oestrogen treatment and stroke: a prospective study. BMJ 1988; 297: 519-22.
13. Thompson SG, Meade TW, Greenberg G. The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women. J Epidemiol Community Health 1989; 43: 173-78.
14. Hunt K, Vessey M, McPherson K. Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br J Obstet Gynaecol 1990; 97: 1080-86.
15. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses Health Study. N Engl J Med 1991; 325: 756-62.
16. Finucane FF, Madans JH, Busch TL, Wolf PH, Kleinman JC. Decreased risk of stroke among postmenopausal hormone users: results from a national cohort. Arch Intern Med 1993; 153: 73-79.
17. Falkeborn M, Persson I, Terent A, Adami HO, Lithell H, Bergström R. Hormone replacement therapy and the risk of stroke: follow-up of a population-based cohort in Sweden. Arch Intern Med 1993; 153: 1201-09.
18. Longstreth WT, Nelson LM, Koepsell TD, van Belle G. Subarachnoid hemorrhage and hormonal factors in women: a population-based case-control study. Ann Intern Med 1994; 121: 168-73.
19. Grodstein F, Stampfer MJ, Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996; 335: 453-61.
20. Klein JP, Keiding N, Kreiner S. Graphical models for panel studies, illustrated on data from the Framingham Heart Study. Stat Med 1995; 14: 1265-90.
21. Darroch JN, Lauritzen SL, Speed TP. Markov fields and log-linear interaction models for contingency tables. Ann Stat 1980; 8: 522-39.
22. Lindegaard O. Oral contraception and risk of cerebral thromboembolic attack: results of a case-control study. BMJ 1993; 306: 956-63.
23. Wermuth N, Lauritzen SL. On substantive research hypotheses, conditional independence graphs and graphical chain models. J R Statist Soc 1990; 52: 21-50.
24. Agresti A. An introduction to categorical data analysis. Chichester: John Wiley, 1990.
25. Nabulsi AA, Folsom AR, White A, et al. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 1933; 328: 1069-75.
26. Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol 1996; 143: 971-78.
27. Feinberg WM, Albers GW, Barnett HJM, et al. Guidelines for the management of transient ischemic attacks. Circulation 1994; 89: 2950-65.
28. Speroff L. The effect of oestrogen-progestogen postmenopausal hormone replacement therapy on the cardiovascular system. Eur Menopause J 1996; 3: 151-63.
29. Salomaa V, Rasi V, Pekkanen J, et al. Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors: the FINRISK hemostasis study. Arterioscler Thromb Vasc Biol 1995; 15; 1549-55.
30. Lindenstrøm E, Boysen G, Nyboe J. Lifestyle factors and risk of cerebrovascular disease in women: the Copenhagen City Heart Study. Stroke 1993; 24: 1468-72.
31. Daly E, Vessey M, Hawkins MM, Carson JL, Gough P, Marsh S. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996; 348: 977-80.
32. Jick H, Derby LE, Myers MW, Vasilakis C, Newton KM. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet 1996; 348: 981-83.
33. Grodstein F, Stampfer MJ, Goldhaber SZ, et al. Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet 1996; 348: 983-87.